With no approved vaccines to date, C. diff causes nearly 30,000 deaths each year in the US, and recurrent infections with the bacterium make up 10%-15% of all hospital-treated infections.

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

A new UConn study reveals that tagatose, a plant-based sugar alternative, shows promise in mitigating Clostridioides difficile (C. difficile) infection, particularly those resistant to antibiotics.

A total of 501 cases of potentially fatal superbug Clostridium difficile (C diff) were notified to health officials in the first ten weeks of this year. Reports of the infection peaked in the third ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Ensure words are spelled correctly. Try rephrasing keywords or using synonyms. Try less specific keywords. Make your queries as concise as possible.

A real-world study of patients with Clostridioides difficile infection (CDI) in Australia over 10 years shows that fecal ... A new study suggests that kids who develop MIS-C (multisystem inflammatory ...

A study of patients who received fecal microbiota transplantation (FMT) for recurrent Clostridioides difficile infection (rCDI) at six US hospitals identifies the biggest risk factors for subsequent ...

This code is released under MIT License.

Domhnall Gleeson and Amy Huberman at the launch of DIFF in January Irish film has gone from strength to strength and come of age over the past few years with Oscar and Bafta recognition and the ...